Hint mode is switched on Switch off
For swift navigation between sections

Cardio Diagnostics Holdings

PDF download

Choose all Reset all
Download Cancel
Organization name
Cardio Diagnostics Holdings, Inc (formerly Mana Capital Acquisition Corp)
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Cardio Diagnostics Holdings, Inc. operates as a biotechnology company. The Company focuses on cardiovascular disease prevention and early detection more accessible, personalized, and precise. Cardio Diagnostics Holdings develops and commercializes a proprietary Artificial Intelligence (AI) driven integrated genetic-epigenetic engine for cardiovascular disease.

Awards

News

19/02/2026 Cardio Diagnostics Holdings: , Including Exhibit 99.1, Shall Not Be Deemed “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, And Shall Not Be Deemed Incorporated By Reference Into Any Filing Of The Company Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Expressly Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits
28/05/2025 Cardio Diagnostics Holdings: Other Events, Financial Statements And Exhibits
12/05/2025 Cardio Diagnostics Holdings: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits
21/02/2025 Cardio Diagnostics Holdings: By This Reference And Will Also Be Available On The Company's Website At Www.cardiodiagnosticsinc.com
02/04/2024 Cardio Diagnostics Holdings: Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001870144
  • EIN
    87-0925574
Registration is required to get access.